Prepared by R.R. Donnelley Financial -- EX-10.17(c)




 Exhibit 10.17(c) 

CONFIDENTIAL 
 [***] Certain information
in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

AMENDMENT #2 TO TASK ORDER #20 

COHERUS Project Number: CHS-0214-04 

MEDPACE Project Number: ETA304 

This Amendment #2 (“Amendment #2”) to Task Order #20 effective as of November 8, 2013 (“Task Order”), is by and
between Coherus Biosciences, Inc., a Delaware corporation with its principal place of business at 201 Redwood Shores Parkway, Suite 200, Redwood City, CA 94065 (“Sponsor”), and Medpace, Inc., with its principal place of
business at 5375 Medpace Way, Cincinnati, Ohio 45227 (“Medpace”). This Amendment #2 shall be effective June 27, 2014. 

WITNESSETH: 

WHEREAS, the Parties have entered into Task Order pursuant and subject to the terms of the Master Service Agreement dated
January 23, 2012, (the “Agreement”); and 
 WHEREAS, the Parties desire to amend Task Order in connection with A Phase
3, Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel® in Subjects With Chronic Plaque Psoriasis (PsO) to increase the
Investigator Payment amount and the Medpace Reference Laboratories (“MRL”) Services and Fees, which includes [***] vendor services. 

NOW, THEREFORE, in consideration of the mutual covenants contained herein, the Parties hereby agree as follows to the revised Scope of
Work. 
  

	 	1.	The [***] Line item included under [***] category in Appendix C: Budget is hereby increased from [***] to [***]; and 

  

	 	2.	The [***] line item included under [***] category in Appendix C: Budget is hereby increased from [***] to [***]; and 

  

	 	3.	The [***] Line item is added under [***] category in Appendix C: Budget for [***] (collectively, the “Increase”). 

  

	 	4.	Appendix F: MRL and [***] Services and Budget attached to Amendment #1 is hereby deleted and replace by Appendix F attached to this Amendment #2. 


 

	 	5.	As a result of the Increase in the Budget, Appendix D: Payment Schedule, attached to the Task Order is hereby amended to include the following: 


A total of [***] is due upon execution of Amendment #2. The remainder of the increase will be paid in accordance with the terms of Appendix D:
Payment Schedule, attached to the Task Order. 

  

			
	



	  	 Medpace Amendment #2 to Task Order #20

Coherus Biosciences, Inc.
 CHS-0214-04
/ ETA 304
 Page 1











 The total amount payable by Sponsor to Medpace under this Amendment #2 for Medpace Direct Fees, Pass-through
Expenses, and Pre-funded Expenses shall not exceed the amount of [***] without prior written consent of both parties. The total value of Task Order and all subsequent amendments is now [***]. 

 

																	
	 	  	Direct Fees	 	  	Pass Through Costs	 	  	Pre-funded
Expenses	 	  	TOTAL	 
	 Task Order #20
	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  
	 Amendment #1
	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  
	 Amendment #2
	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  
		  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 
	 TOTAL
	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  
		  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 

 All other provisions of the Agreement and Task Order shall remain unchanged and in effect. 

IN WITNESS WHEREOF, the Parties have hereunto signed this Amendment #2 to Task Order in their official capacities which shall be effective on the day
and year listed above. 
  

			
	MEDPACE, INC.
		
	 Signature: 
	 	 /s/ John Wynne



			
	 By:
	 	 John Wynne

		 	(Print Name)


			
	 Title:
	 	 Vice President Commercial Operations

	
	 COHERUS BIOSCIENCES, INC.

		
	 Signature:
	 	 /s/ Dennis M. Lanfear



			
	 By:
	 	 Dennis M. Lanfear

		 	(Print Name)
	 Title:
	 	 President & CEO


  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and 
 Exchange Commission. Confidential treatment has been requested with
respect to the omitted portions. 

  

			
	



	  	 Medpace Amendment #2 to Task Order #20

Coherus Biosciences, Inc.
 CHS-0214-04
/ ETA 304
 Page 2












					
	Sponsor:	 	Coherus Biosciences	  	23-Jun-14
	Protocol:	 	CHS-0214-04	  	

  

					
	 [***]
	  	 	[***]	  
	 [***]
	  	 	[***]	  
	 [***]
	  	 	[***]	  
	 [***]
	  	 	[***]	  
	 [***]
	  	 	[***]	  
		  	  
	  
	 
	 Total Medpace Reference Laboratories Fees
	  	 	[***]	  
		  	  
	  
	 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and 
 Exchange Commission. Confidential treatment has been requested with
respect to the omitted portions. 

  

			
	



	  	 Medpace Amendment #2 to Task Order #20

Coherus Biosciences, Inc.
 CHS-0214-04
/ ETA 304
 Page 3











 Medpace Reference Laboratories Fee Estimate 

 

																																																															
	Sponsor:	 	    Coherus Biosciences	 
	Protocol:	 	    CHS-0214-04	 	[***]	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	[***]	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	Unit Cost	 	 	[***]	 	 	[***]	 	 	[***]	 	 	[***]	 	 	[***]	 	 	[***]	 	 	[***]	 	 	[***]	 	 	[***]	 	 	[***]	 	 	[***]	 	 	Total
Number
of Units	 	 	Cost	 	 	Subtotal	 
	 Laboratory Tests
	   
	 	 	[***]	  
		 	 [***]
	 	 	[***]	  	 				 	 	[***]	  	 				 				 				 	 	[***]	  	 	 	[***]	  	 				 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 			
		 	 [***]
	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 				 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 			
		 	 [***]
	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 				 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 			
		 	 [***]
	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 				 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 			
		 	 [***]
	 	 	[***]	  	 	 	[***]	  	 				 				 				 				 				 				 				 				 				 				 	 	[***]	  	 	 	[***]	  	 			
	 Laboratory Support Services
	   
	 	 	[***]	  
	 [***]
	 		 				 				 				 				 				 				 				 				 				 				 				 				 				 				 			
		 	[***]	 	 	[***]	  	 				 				 				 				 				 				 				 				 				 				 				 	 	[***]	  	 	 	[***]	  	 			
		 	[***]	 	 	[***]	  	 				 				 				 				 				 				 				 				 				 				 				 				 				 			
		 	[***]	 	 	[***]	  	 				 				 				 				 				 				 				 				 				 				 				 				 				 			
		 	[***]	 	 	[***]	  	 				 				 				 				 				 				 				 				 				 				 				 	 	[***]	  	 	 	[***]	  	 			
		 	[***]	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 				 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 			
		 	[***]	 	 	[***]	  	 				 				 				 				 				 				 				 				 				 				 				 				 				 			
		 	[***]	 	 	[***]	  	 				 				 				 				 				 				 				 				 				 				 				 	 	[***]	  	 	 	[***]	  	 			
		 	[***]	 	 	[***]	  	 				 				 				 				 				 				 				 				 				 				 				 	 	[***]	  	 	 	[***]	  	 			
	 [***]
	 		 				 				 				 				 				 				 				 				 				 				 				 				 				 				 			
		 	[***]	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 				 	 	[***]	  	 				 				 	 	[***]	  	 	 	[***]	  	 			
		 	[***]	 	 	[***]	  	 				 				 	 	[***]	  	 				 				 				 				 	 	[***]	  	 				 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 			
		 	[***]	 	 	[***]	  	 				 				 				 				 				 				 				 				 				 				 				 	 	[***]	  	 	 	[***]	  	 			
		 	[***]	 	 	[***]	  	 				 				 				 				 				 				 				 				 				 				 				 	 	[***]	  	 	 	[***]	  	 			
		 	[***]	 	 	[***]	  	 				 				 				 				 				 				 				 				 				 				 				 	 	[***]	  	 	 	[***]	  	 			
		 	[***]	 	 	[***]	  	 				 				 				 				 				 				 				 				 				 				 				 	 	[***]	  	 	 	[***]	  	 			
		 	[***]	 	 	[***]	  	 				 				 				 				 				 				 				 				 				 				 				 	 	[***]	  	 	 	[***]	  	 			
	 [***]
	 		 				 				 				 				 				 				 				 				 				 				 				 				 				 				 			
		 	[***]	 	 	[***]	  	 	 	[***]	  	 				 				 				 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 			
		 	[***]	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 			
		 	[***]	 	 	[***]	  	 				 				 				 				 				 				 				 				 				 				 			
		 	[***]	 	 	[***]	  	 				 				 				 				 				 				 				 				 			
		 	[***]	 	 	[***]	  	 				 				 				 				 				 				 				 				 			
	 Total Medpace Reference Laboratory Fees
	   
	 	 	[***]	  

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and 
 Exchange Commission. Confidential treatment has been requested with
respect to the omitted portions. 

  

			
	



	  	 Medpace Amendment #2 to Task Order #20

Coherus Biosciences, Inc.
 CHS-0214-04
/ ETA 304
 Page 4











 Medpace Reference Laboratories Fee Estimate 

 

																																																													
	Sponsor:	 	    Coherus Biosciences	 
	Protocol:	 	    CHS-0214-04	 	[***]	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	[***]	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 Unit Cost
	 	[***]	 	 	[***]	 	 	[***]	 	 	[***]	 	 	[***]	 	 	[***]	 	 	[***]	 	 	[***]	 	 	[***]	 	 	[***]	 	 	[***]	 	 	Total
Number
of Units	 	 	Cost	 	 	Subtotal	 
	 Laboratory Tests
	   
	 	 	[***]	  
		 	[***]	 	[***]	 				 	 	[***]	  	 				 				 				 	 	[***]	  	 	 	[***]	  	 				 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 			
		 	[***]	 	[***]	 	 	[***]	  	 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 				 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 			
		 	[***]	 	[***]	 	 	[***]	  	 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 				 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 			
		 	[***]	 	[***]	 	 	[***]	  	 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 				 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 			
		 	[***]	 	[***]	 	 	[***]	  	 				 				 				 				 				 				 				 				 				 				 	 	[***]	  	 	 	[***]	  	 			
	 Laboratory Support Services
	   
	 	 	[***]	  
	 [***]
	 		 		 				 				 				 				 				 				 				 				 				 				 				 				 			
		 	[***]	 	[***]	 				 				 				 				 				 				 				 				 				 				 				 	 	[***]	  	 	 	[***]	  	 			
		 	[***]	 	[***]	 	 	[***]	  	 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 				 	 	[***]	  	 				 				 	 	[***]	  	 	 	[***]	  	 			
		 	[***]	 	[***]	 				 				 				 				 				 				 				 				 				 				 				 	 	[***]	  	 	 	[***]	  	 			
		 	[***]	 	[***]	 				 				 				 				 				 				 				 				 				 				 				 	 	[***]	  	 	 	[***]	  	 			
	 [***]
	 		 		 				 				 				 				 				 				 				 				 				 				 				 				 			
		 	[***]	 	[***]	 	 	[***]	  	 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 			
		 	[***]	 	[***]	 				 				 	 	[***]	  	 				 				 				 				 	 	[***]	  	 				 				 				 	 	[***]	  	 	 	[***]	  	 			
		 	[***]	 	[***]	 				 				 				 				 				 				 				 				 				 				 				 	 	[***]	  	 	 	[***]	  	 			
		 	[***]	 	[***]	 				 				 				 				 				 				 				 				 				 				 				 	 	[***]	  	 	 	[***]	  	 			
		 	[***]	 	[***]	 				 				 				 				 				 				 				 				 				 				 				 	 	[***]	  	 	 	[***]	  	 			
		 	[***]	 	[***]	 				 				 				 				 				 				 				 				 				 				 				 	 	[***]	  	 	 	[***]	  	 			
		 	[***]	 	[***]	 				 				 				 				 				 				 				 				 				 				 				 	 	[***]	  	 	 	[***]	  	 			
		 	[***]	 	[***]	 				 				 				 				 				 				 				 				 				 				 				 	 	[***]	  	 	 	[***]	  	 			
	 [***]
	 		 		 				 				 				 				 				 				 				 				 				 				 				 				 			
		 	[***]	 	[***]	 				 	 	[***]	  	 				 				 				 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 			
		 	[***]	 	[***]	 				 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 			
		 	[***]	 	[***]	 				 				 				 				 				 				 				 				 				 				 				 				 			
		 	[***]	 	[***]	 				 				 				 				 				 				 				 				 			
		 	[***]	 	[***]	 				 				 				 				 				 				 				 				 			
	 Total Medpace Reference Laboratory Fees
	   
	 	 	[***]	  

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and 
 Exchange Commission. Confidential treatment has been requested with
respect to the omitted portions. 

  

			
	



	  	 Medpace Amendment #2 to Task Order #20

Coherus Biosciences, Inc.
 CHS-0214-04
/ ETA 304
 Page 5











 Medpace Reference Laboratories Fee Estimate 

 

																																																															
	Sponsor:	 	    Coherus Biosciences	 
	Protocol:	 	    CHS-0214-04	 	[***]	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	[***]	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	Unit Cost	 	 	[***]	 	 	[***]	 	 	[***]	 	 	[***]	 	 	[***]	 	 	[***]	 	 	[***]	 	 	[***]	 	 	[***]	 	 	[***]	 	 	[***]	 	 	Total
Number
of Units	 	 	Cost	 	 	Subtotal	 
	 Laboratory Tests
	   
	 	 	[***]	  
		 	 [***]
	 	 	[***]	  	 				 	 	[***]	  	 				 				 				 	 	[***]	  	 	 	[***]	  	 				 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 			
		 	 [***]
	 	 	[***]	  	 				 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 				 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 			
		 	 [***]
	 	 	[***]	  	 				 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 				 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 			
		 	 [***]
	 	 	[***]	  	 				 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 				 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 			
		 	 [***]
	 	 	[***]	  	 				 				 				 				 				 				 				 				 				 				 				 	 	[***]	  	 	 	[***]	  	 			
	 Laboratory Support Services
	   
	 	 	[***]	  
	 [***]
	 		 				 				 				 				 				 				 				 				 				 				 				 				 				 				 			
		 	 [***]
	 	 	[***]	  	 				 				 				 				 				 				 				 				 				 				 				 	 	[***]	  	 	 	[***]	  	 			
		 	 [***]
	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 				 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 			
		 	 [***]
	 	 	[***]	  	 				 				 				 				 				 				 				 				 				 				 				 	 	[***]	  	 	 	[***]	  	 			
		 	 [***]
	 	 	[***]	  	 				 				 				 				 				 				 				 				 				 				 				 	 	[***]	  	 	 	[***]	  	 			
	 [***]
	 		 				 				 				 				 				 				 				 				 				 				 				 				 				 				 			
		 	 [***]
	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 				 	 	[***]	  	 				 				 	 	[***]	  	 	 	[***]	  	 			
		 	 [***]
	 	 	[***]	  	 				 				 	 	[***]	  	 				 				 				 				 	 	[***]	  	 				 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 			
		 	 [***]
	 	 	[***]	  	 				 				 				 				 				 				 				 				 				 				 				 	 	[***]	  	 	 	[***]	  	 			
		 	 [***]
	 	 	[***]	  	 				 				 				 				 				 				 				 				 				 				 				 	 	[***]	  	 	 	[***]	  	 			
		 	 [***]
	 	 	[***]	  	 				 				 				 				 				 				 				 				 				 				 				 	 	[***]	  	 	 	[***]	  	 			
		 	 [***]
	 	 	[***]	  	 				 				 				 				 				 				 				 				 				 				 				 	 	[***]	  	 	 	[***]	  	 			
		 	 [***]
	 	 	[***]	  	 				 				 				 				 				 				 				 				 				 				 				 	 	[***]	  	 	 	[***]	  	 			
		 	 [***]
	 	 	[***]	  	 				 				 				 				 				 				 				 				 				 				 				 	 	[***]	  	 	 	[***]	  	 			
	 [***]
	 		 				 				 				 				 				 				 				 				 				 				 				 				 				 				 			
		 	 [***]
	 	 	[***]	  	 				 	 	[***]	  	 				 				 				 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 			
		 	 [***]
	 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 	 	[***]	  	 				 	 	[***]	  	 	 	[***]	  	 			
		 	 [***]
	 	 	[***]	  	 				 				 				 				 				 				 				 				 				 				 				 				 				 			
		 	 [***]
	 	 	[***]	  	 				 				 				 				 				 				 				 				 				 				 				 				 				 			
		 	 [***]
	 	 	[***]	  	 				 				 				 				 				 				 				 				 				 				 				 				 				 			
	 Total Medpace Reference Laboratory Fees
	   
	 	 	[***]	  

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and 
 Exchange Commission. Confidential treatment has been requested with
respect to the omitted portions. 

  

			
	



	  	 Medpace Amendment #2 to Task Order #20

Coherus Biosciences, Inc.
 CHS-0214-04
/ ETA 304
 Page 6











 Medpace Reference Laboratories Pass Through Estimate 

 

																					
	Sponsor:          Coherus Biosciences	  	 	 	  	 	 	  	 	 	  	 	 	  	 	 
	Protocol:         CHS-0214-04	  	 	 	  	 	 	  	 	 	  	 	 	  	 	 
	 	  	 	 	  	Average
Cost per Unit	 	  	Estimated
Number of
Units	 	  	Total
Cost	 	  	Subtotal	 
	 Pass Through Estimates
	  				  				  				  				  	 	[***]	  
		  				  				  				  				  	  
	  
	 
	 [***]
	  				  				  				  				  			
		  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  			
		  	 	[***]	  	  	 	[***]	  	  				  				  			
		  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  			
		  	 	[***]	  	  				  				  	 	[***]	  	  			
		  				  				  				  				  	  
	  
	 
	 Total Estimated Medpace Reference Laboratory Pass-Through Fees
	   
	  				  	 	[***]	  
		  				  				  				  				  	  
	  
	 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and 
 Exchange Commission. Confidential treatment has been requested with
respect to the omitted portions. 

  

			
	



	  	 Medpace Amendment #2 to Task Order #20

Coherus Biosciences, Inc.
 CHS-0214-04
/ ETA 304
 Page 7











 Transportation Costs 
  

																																																					
	 Country
	  	Sites	 	  	Number
Screened	 	  	Number 
Randomized	 	  	Number
Ambient /
Refrigerate
shipments	 	  	Number 
Frozen
Shipments	 	  	[***]	 	  	[***]	 	  	[***]	 	  	[***]	 	  	[***]	 	  	[***]	 	  	[***]	 	  	[***]	 
	 [***]
	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  
	 [***]
	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  
	 [***]
	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  
	 [***]
	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  
	 [***]
	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  
	 [***]
	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  
	 [***]
	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  
	 [***]
	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  
	 [***]
	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  
	 [***]
	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  
	 [***]
	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  
		  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  				  	  
	  
	 	  				  	  
	  
	 	  				  	  
	  
	 	  				  	  
	  
	 
	 Total
	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  				  	 	[***]	  	  				  	 	[***]	  	  				  	 	[***]	  	  				  	 	[***]	  
		  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  				  	  
	  
	 	  				  	  
	  
	 	  				  	  
	  
	 	  				  	  
	  
	 
		  				  				  				  	 	[***]	  	  				  				  				  				  				  	 	[***]	  	  	 	[***]	  	  				  			
		  				  				  				  	 	[***]	  	  				  				  				  				  				  	 	[***]	  	  	 	[***]	  	  				  			
		  				  				  				  	 	[***]	  	  				  				  				  				  				  	 	[***]	  	  	 	[***]	  	  				  			
		  				  				  				  				  				  				  	 	[***]	  	  				  	 	[***]	  	  				  	 	[***]	  	  				  	 	[***]	  

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and 
 Exchange Commission. Confidential treatment has been requested with
respect to the omitted portions. 

  

			
	



	  	 Medpace Amendment #2 to Task Order #20

Coherus Biosciences, Inc.
 CHS-0214-04
/ ETA 304
 Page 8












																																																									
	Transportation Costs	  	  				  				  				  				  				  				  	 	[***]	  	  				  				  				  			
															
	 Country
	  	Sites	 	  	Number
Screened	 	  	Number 
Randomized	 	  	Number
Ambient /
Refrigerate
Shipments	 	  	Number 
Frozen
Shipments	 	  	[***]	 	  	[***]	 	  	[***]	 	  	[***]	 	  	[***]	 	  	[***]	 	  	[***]	 	  	[***]	 	  	 	 
	 [***]
	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  			
	 [***]
	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  			
	 [***]
	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  			
	 [***]
	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  			
	 [***]
	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  			
	 [***]
	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  			
	 [***]
	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  			
	 [***]
	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  			
	 [***]
	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  			
	 [***]
	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  			
	 [***]
	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  			
		  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  				  	  
	  
	 	  				  	  
	  
	 	  				  	  
	  
	 	  				  	  
	  
	 	  			
	 Total
	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  				  	 	[***]	  	  				  	 	[***]	  	  				  	 	[***]	  	  				  	 	[***]	  	  			
		  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  				  	  
	  
	 	  				  	  
	  
	 	  				  	  
	  
	 	  				  	  
	  
	 	  			
		  				  				  				  	 	[***]	  	  				  				  				  				  				  	 	[***]	  	  	 	[***]	  	  				  				  			
		  				  				  				  	 	[***]	  	  				  				  				  				  				  				  				  				  				  			
		  				  				  				  	 	[***]	  	  				  				  				  				  				  				  				  				  				  			
		  				  				  				  				  				  				  	 	[***]	  	  				  	 	[***]	  	  				  	 	[***]	  	  				  	 	[***]	  	  	 	[***]	  

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and 
 Exchange Commission. Confidential treatment has been requested with
respect to the omitted portions. 

  

			
	



	  	 Medpace Amendment #2 to Task Order #20

Coherus Biosciences, Inc.
 CHS-0214-04
/ ETA 304
 Page 9